The Prevalence of Hyper-Lp(a)-Emia in the PMMHRI-Lp(a) Registry

计划入组 2,000 人 · 首次发布于 2024 年 9 月 24 日

A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)

计划入组 42 人 · 首次发布于 2014 年 9 月 16 日

Sandostatine® LP and Hyperinsulinism

计划入组 10 人 · 首次发布于 2009 年 9 月 30 日

Iron(Citranatal B-calm Kit, Citranatal Harmony, Concept Ob, Ferralet 90, Natafort, Vitafol-one)

<dd class="col-xl-8 col-md-9 col-sm-8">Fe</dd>

Iron polymaltose(Tandem, Tandem Plus)

<dd class="col-xl-8 col-md-9 col-sm-8">C₁₂H₂₅FeO₁₄</dd>

Ferricrocin-iron

C₂₈H₅₀FeN₉O₁₃

Fortress Biotech

United States

FORTRESS LOGISTICS PTY LTD

Australia

Iron Horse Diagnostics, Inc

United States

Federal Circuit Rules Omitted Coinventor Renders Patents Invalid When Correction Procedures Cannot Be Met

Fortress Biotech's Emrosi Receives FDA Approval for Rosacea Treatment

Fortress Biotech Highlights FDA Approval of Emrosi and Cosibelimab's Upcoming PDUFA Date